Dr. Martens plc FY21 results presentation
17 giu 2021 INTRODUCTION TO DR. MARTENS. Iconic brand and iconic product. Broad appeal. Consumers love their Docs. Direct to consumer led model.
DR. MARTENS PLC ANNUAL REPORT 2022
31 mag 2022 The first boot was born on 1 April 1960 in Wollaston England
Prospectus - Dr. Martens plc
29 gen 2021 attached prospectus (the "Prospectus") relating to Dr. Martens plc (the "Company") dated 29 January 2021 accessed from this page or.
Dr. Martens plc Annual Report 2021
27 lug 2021 Annual Report 2021 Dr. Martens plc. WHAT WE DO. Dr. Martens is an iconic global brand and one of the most recognised footwear brands in the ...
Dr. Martens plc Sustainability Report
Creating a fairer and more sustainable world is a challenge. But if there's one thing. Dr. Martens is good at it's being brave and standing up for what.
FY22 results presentation
1 giu 2022 Dr. Martens brand is stronger than ever. Confident in year ahead and continued delivery of strategy. Page 4. Page 5. AGENDA.
FIRST HALF RESULTS FY22
9 dic 2021 THIS IS WHERE DR. MARTENS IS HEADING. THIS IS WHAT WE'RE WORKING TOWARDS ... Barnes@drmartens.com. Mobile: +44 7825 187465. Sunena Dhuna.
AND TRANSPARENCY IN THE SUPPLY CHAIN STATEMENT
This statement covers Dr. Martens plc and other group companies and is made pursuant to section 54 of the Modern Slavery Act 2015 and California Transparency in
Dr. Martens plc FY21 results statement
17 giu 2021 Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking.
Dr. Martens Modern Slavery and transparency in the supply chain
This statement covers Dr. Martens Airwair Group Ltd. and other group companies. This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 and
Blundstone vs Dr Martens Chelsea Boots Review - Reviewed
Home Dr Martens plc (LSE: DOCS)
What is Dr Martens?
What is Dr. Martens? Docs will forever remain the coolest thing in your closet—even after you've worn them down to their soles. Dr. Martens, commonly d? "Doc Martens" or "Docs," may initially evoke images of 6-inch goth-looking combat boots, but its beginnings are a little more humble.
How versatile is Dr Martens 2976?
The outer sole and heel area, usually wooden on most boots, has the signature Dr. Martens rubber with grooved sides that looks sleek. How Versatile is Dr. Martens 2976? These boots are very versatile. You can wear and pair them with just about anything, which is why I got them.
Are Dr Martens good boots?
– Review Dr. Martens boots are the most common boots I’ve seen worn. You can spot a person wearing docs by the heel tag or famous yellow stitching on the soles. There has been this hype over them for years that I never quite understood. A few months ago, I needed a comfortable pair of versatile boots, one I can easily slip on and slip off.
Does Dr Martens kick against the norm?
Whatever you call them (Doc Martens, Docs, DMs), one thing’s for certain: Dr. Martens kicks against the norm.
ELECTRONIC TRANSMISSION DISCLAIMER
STRICTLY NOT TO BE FORWARDED TO ANY OTHER PERSONS
IMPORTANT: You must read the following disclaimer before continuing. This electronic transmission applies to the attached
Prospectus and you are therefore advised to read this disclaimer carefully before reading, accessing or making any other use of the
attached prospectus (the "Prospectus") relating to Dr. Martens plc (the "Company") dated 29 January 2021 accessed from this page or
otherwise received as a result of such access and you are therefore advised to read this disclaimer carefully before reading, accessing
or making any other use of the attached Prospectus. In accessing the attached Prospectus, you agree to be bound by the following
terms and conditions, including any modifications to them from time to time, each time you receive any information from us as a
result of such access. You acknowledge that this electronic transmission and the delivery of the attached Prospectus is confidential
and intended for you only and you agree you will not forward, reproduce or publish this electronic transmission or the attached
Prospectus to any other person. The Prospectus has been prepared solely in connection with the proposed offer to certain institutional
investors (the "Offer") of ordinary shares (the "Shares") of the Company. The Prospectus has been published in connection with the
admission of the Shares to the premium listing segment of the Official List of the UK Financial Conduct Authority (the "FCA") and
to trading on London Stock Exchange plc's main market for listed securities (together, "Admission"). The Prospectus has been
approved by the FCA as a prospectus prepared in accordance with the Prospectus Regulation Rules made under section 73A of the
Financial Services and Markets Act 2000. The Prospectus is available on the Company's website at www.drmartensplc.com. Pricing
information and other related disclosures are expected to be published on this website. Prospective investors are advised to access
such information prior to making an investment decision. THIS ELECTRONIC TRANSMISSION AND THE ATTACHED PROSPECTUS MAY ONLY BE DISTRIBUTED IN "OFFSHORE TRANSACTIONS" AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE US SECURITIESACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR WITHIN THE UNITED STATES TO PERSONS
REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS ("QIBs") AS DEFINED IN RULE 144A UNDER THE US SECURITIES ACT ("RULE 144A") OR ANOTHER EXEMPTION FROM, OR TRANSACTION NOT SUBJECT TO, REGISTRATION UNDER THE US SECURITIES ACT. ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE ATTACHED PROSPECTUS IN WHOLE OR IN PART IS UNAUTHORISED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE US SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS. NOTHING IN THIS ELECTRONIC TRANSMISSION AND THE ATTACHED PROSPECTUS CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) TO A PERSON THAT THE HOLDER AND ANY PERSON ACTING ON ITS BEHALF REASONABLY BELIEVES IS A QIB AS DEFINED IN, OR IN RELIANCE ON, RULE 144A, OR ANOTHER EXEMPTION FROM, OR TRANSACTION NOT SUBJECT TO, THEREGISTRATION REQUIREMENTS OF THE US SECURITIES ACT, OR (2) IN AN OFFSHORE TRANSACTION IN
ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE US SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. CANADIAN INVESTORS ARE ADVISED THAT THIS EMAIL AND THE PROSPECTUS ATTACHED HERETO MAY ONLY BE TRANSMITTED IN THOSE JURISDICTIONS IN CANADA AND TO THOSE PERSONS WHERE AND TO WHOM THEY MAY BE LAWFULLY OFFERED FOR SALE AND THEREIN ONLY BY PERSONS PERMITTED TO SELL SUCH SECURITIES. THE PROSPECTUS ATTACHED HERETO IS NOT AND UNDER NO CIRCUMSTANCES IS TO BE CONSTRUED AS, AN ADVERTISEMENT OR A PUBLIC OFFERING IN CANADA. NO SECURITIES COMMISSION OR SIMILAR AUTHORITY IN CANADA HAS REVIEWED OR IN ANY WAY PASSED UPON THE PROSPECTUS ATTACHED HERETO OR THE MERITS OF THE SECURITIES DESCRIBED THEREIN AND ANY REPRESENTATION TO THE CONTRARY IS AN OFFENCE. THE DISTRIBUTION OF THE SECURITIES CONTAINED IN THE PROSPECTUSATTACHED HERETO IS BEING MADE ON A PRIVATE PLACEMENT BASIS ONLY AND IS EXEMPT FROM THE
REQUIREMENT THAT THE COMPANY PREPARE AND FILE A PROSPECTUS WITH THE RELEVANT CANADIANSECURITIES REGULATORY AUTHORITIES.
ANY FORWARDING, REDISTRIBUTION OR REPRODUCTION OF THE PROSPECTUS IN WHOLE OR IN PART ISUNAUTHORISED. FAILURE TO COMPLY WITH THIS DIRECTIVE MAY RESULT IN A VIOLATION OF THE US
SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.This electronic transmission and the attached Prospectus and the Offer when made are only addressed to and directed at persons in
member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU)
2017/1129 (the "Prospectus Regulation") ("Qualified Investors"). In the United Kingdom, this electronic transmission and the
attached Prospectus is being distributed only to, and is directed only at, persons: (A) (i) who have professional experience in matters
relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order
2005, as amended (the "Order"), (ii) falling within Article 49(2)(a) to (d) of the Order and (iii) to whom it may otherwise lawfully be
communicated; and (B) who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation
(EU) 2017/1129) as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018 (all such persons
together being referred to as "relevant persons"). This electronic transmission and the attached Prospectus must not be acted on or
relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the European Economic
Area, by persons who are not Qualified Investors. Any investment or investment activity to which the attached Prospectus relates is
available only to (i) in the United Kingdom, relevant persons, and (ii) in any member state of the European Economic Area, Qualified
Investors, and will be engaged in only with such persons.Confirmation of Your Representation: This electronic transmission and the attached Prospectus is delivered to you on the basis
that you are deemed to have represented to the Company and Morgan Stanley & Co. International plc (the "Sponsor"), Goldman
Sachs International, (with Morgan Stanley & Co. International plc, the "Joint Global Co-ordinators"), Barclays Bank PLC, HSBC
Bank plc, Merrill Lynch International and RBC Europe Limited (along with the Joint Global Co-ordinators, the "Joint Bookrunners"),
Banco Santander, S.A. and Raiffeisen Bank International AG (the "Co-lead Managers", and along with the Joint Bookrunners, the
"Underwriters"), that (i) you are (a) a QIB acquiring such securities for its own account or for the account of another QIB or (b)
acquiring such securities in "offshore transactions", as defined in, and in reliance on, Regulation S under the US Securities Act; (ii) if
you are in the United Kingdom, you are a relevant person and/or a relevant person who is acting on behalf of relevant persons in the
United Kingdom to the extent you are acting on behalf of persons or entities in the United Kingdom; (iii) if you are in any member
state of the European Economic Area, you are a Qualified Investor and/or a Qualified Investor acting on behalf of Qualified Investors
to the extent you are acting on behalf of persons or entities in the European Economic Area; (iv) the securities acquired by you in the
offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or
resale to, any person in circumstances which may constitute or give rise to an offer of any securities to the public other than their
offer or resale, in the United Kingdom. to relevant persons, and in any member state of the European Economic Area, to Qualified
Investors; (v) if you are outside the United States, United Kingdom and European Economic Area (and the electronic mail address
that you provided and to which this Prospectus has been delivered are not located in such jurisdictions) you are a person into whose
possession this Prospectus may lawfully be delivered in accordance with the laws of the jurisdiction in which you are located; and
(vi) you are an institutional investor that is eligible to receive the attached Prospectus and you consent to delivery by electronic
transmission.For investors resident in British Columbia, Alberta, Manitoba, Ontario and Quebec (the "Relevant Provinces"). You acknowledge and
agree that (a) the securities described in the attached Prospectus are only being distributed to investors resident in the Relevant
Provinces, (b) you are (i) an "accredited investor" as such term is defined in National Instrument 45-106 Prospectus Exemptions and
(ii) a "permitted client", as such term is defined in National Instrument 31-101 Registration Requirements. Exemptions and Ongoing
Registrant Obligations(NI 31-103) and are purchasing the Shares from a dealer registered in Canada or relying on the "international
dealer exemption" contained in NI 31-103; and (c) where required by law, you are participating in the offering as principal for your
own account and not as agent.You are reminded that you have received this electronic transmission and the attached Prospectus on the basis that you are a person
into whose possession the attached Prospectus may be lawfully delivered in accordance with the laws of the jurisdiction in which you
are located and you may not nor are you authorised to deliver the attached Prospectus, electronically or otherwise, to any other
person. The attached Prospectus has been made available to you in an electronic form. You are reminded that Prospectus transmitted
via this medium may be altered or changed during the process of electronic transmission and consequently neither the Company, the
Underwriters, the Financial Adviser nor any of their respective affiliates accepts any liability or responsibility whatsoever in respect
of any difference between the Prospectus distributed to you in electronic format and the hard copy version. A hard copy of the
Prospectus will be made available to you only upon request.By accessing the linked Prospectus, you consent to receiving it in electronic form. None of the Underwriters, the Financial Adviser
nor any of their respective affiliates accepts any responsibility whatsoever for the contents of the attached Prospectus or for any
statement made or purported to be made by it, or on its behalf, in connection with the Company or the Shares. The Underwriters, the
Financial Adviser and each of their respective affiliates, each accordingly disclaims all and any liability whether arising in tort,
contract or otherwise which they might otherwise have in respect of such Prospectus or any such statement. No representation or
warranty express or implied, is made by any of the Underwriters or any of their respective affiliates as to the accuracy, completeness,
verification or sufficiency of the information set out in the attached Prospectus.The Underwriters and the Financial Adviser are acting exclusively for the Company and no one else in connection with the Offer.
They will not regard any other person (whether or not a recipient of the attached Prospectus) as their client in relation to the Offer and
will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for
giving advice in relation to the Offer or any transaction or arrangement referred to in the attached Prospectus.
Restriction: Nothing in this electronic transmission constitutes, and this electronic transmission may not be used in connection with,
an offer of securities for sale to persons other than the specified categories of institutional buyers described above and to whom it is
directed and access has been limited so that it shall not constitute a general solicitation. If you have gained access to this transmission
contrary to the foregoing restrictions, you will be unable to purchase any of the securities described therein.
You are responsible for protecting against viruses and other destructive items. Your receipt of this Prospectus via electronic
transmission is at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses and other items
of a destructive nature.6800$5<
QXPEHULQJVHTXHQFHRIWKH(OHPHQWV
$'DWHRIDSSURYDORIWKHSURVSHFWXV $:DUQLQJ6(&7,21%².(<,1)250$7,21217+(,668(5
%:KRLVWKHLVVXHURIWKHVHFXULWLHV" %3ULQFLSDODFWLYLWLHV %0DMRUVKDUHKROGHUV ,PPHGLDWHO\SULRUWR
$GPLVVLRQ1XPEHURI6KDUHVWREH
VROGLQWKH2IIHU,PPHGLDWHO\
IROORZLQJ
$GPLVVLRQ6KDUHKROGHUV1XPEHURI6KDUHV3HUFHQWDJH
RILVVXHG
VKDUHFDSLWDO1XPEHU
RI6KDUHV3HUFHQWDJH
RILVVXHG
VKDUHFDSLWDO1XPEHU
RI6KDUHV3HUFHQWDJH
RILVVXHG
VKDUHFDSLWDO
SDULSDVVX
%.H\PDQDJLQJGLUHFWRUV %,GHQWLW\RIWKHVWDWXWRU\DXGLWRUV +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ6HOHFWHGILQDQFLDOLQIRUPDWLRQ
...PXQDXGLWHG5HYHQXH
*URVVSURILW2SHUDWLQJSURILW
(%,7'$ (%,7'$SRVWH[FHSWLRQDOLWHPV2SHUDWLQJSURILW
3URILWEHIRUHLQFRPHWD[
3URILWORVVIRUWKHSHULRG\HDU
DWWULEXWDEOHWRWKHRZQHUVRIWKHSDUHQW
5HFRQFLOLDWLRQRI(%,7'$WR(%,7'$
SUHVHQWHGRQDQ,$6EDVLV
(%,7'$ ...P1RQFXUUHQWDVVHWV &XUUHQWDVVHWV7RWDODVVHWV
$VDW0DUFK$VDW6HSWHPEHU ...P&XUUHQWOLDELOLWLHV1RQFXUUHQWOLDELOLWLHV
7RWDOOLDELOLWLHV
1HWDVVHWVOLDELOLWLHV
(TXLW\DWWULEXWDEOHWRRZQHUVRIWKHSDUHQW ...PXQDXGLWHG
6HSWHPEHU
...PXQDXGLWHG
2SHUDWLQJFDVKIORZ
)UHHFDVKIORZ &ORVLQJFDVK3URIRUPDILQDQFLDOLQIRUPDWLRQ
*URXSQHWDVVHWVDW
GRZQXQGHUWKH1HZ
IRUPDQHWDVVHWVDW
&XUUHQWDVVHWV7RWDODVVHWV
&XUUHQWOLDELOLWLHV1RQFXUUHQWOLDELOLWLHV
7RWDOOLDELOLWLHV
1HWDVVHWV²²
+LVWRULFDO)LQDQFLDO,QIRUPDWLRQ5HRUJDQLVDWLRQ$GGLWLRQDO,QIRUPDWLRQ
&:KDWDUHWKHPDLQIHDWXUHVRIWKHVHFXULWLHV" &7\SHFODVVDQG,6,1 &5LJKWVDWWDFKLQJWRWKH6KDUHV &5HVWULFWLRQVRQWUDQVIHU &'LYLGHQGRUSD\RXWSROLF\ &:KHUHZLOOWKHVHFXULWLHVEHWUDGHG" $'0,66,217275$',1*21$5(*8/$7('0$5.(7 ':K\LVWKLVSURVSHFWXVEHLQJSURGXFHG" 3DUW5LVN)DFWRUV
XQFHUWDLQWLHVGHVFULEHGEHORZ
3URVSHFWXVDQGWKHLUSHUVRQDOFLUFXPVWDQFHV
3URVSHFWXV
FRXOGEHDGYHUVHO\DIIHFWHG
7KH&29,'SDQGHPLFKDVDIIHFWHGDQG
DQGSURVSHFWV5LVN)DFWRUV
)DFWRUV ,IWKH*URXSHQFRXQWHUV ,IWKH*URXSLVXQDEOH5LVN)DFWRUV
PD\EHKDUPHG
5LVN)DFWRUV
HIILFLHQF\LQLWLDWLYHVLWXQGHUWDNHV
EXVLQHVVFRXOGEHDGYHUVHO\DIIHFWHG
LWVEXVLQHVV
RISRWHQWLDORSHUDWLRQDOULVNV
5LVNVUHODWLQJWRFRPSOLDQFHDQGUHJXODWLRQ
UHSXWDWLRQDQGH[SRVHLWWROLWLJDWLRQ
'U0DUWHQVEUDQG5LVN)DFWRUVHQYLURQPHQWDODQGRWKHUODZVDQGUHJXODWLRQV
5LVNVUHODWLQJWRWKH2IIHUDQGWKH6KDUHV
5LVN)DFWRUV
GHYHORSRUEHVXVWDLQHG
WKDWWKHVHVDOHVFRXOGRFFXU
DEOHWRSDUWLFLSDWHLQIXWXUHHTXLW\RIIHULQJV
RWKHU6KDUHKROGHUV
3$57 *HQHUDO2YHUDOORWPHQWDQGVWDELOLVDWLRQ
SDULSDVVX
3UHVHQWDWLRQRIILQDQFLDOLQIRUPDWLRQ
,QIRUPDWLRQ )LQDQFLDOLQIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ3URIRUPDILQDQFLDOLQIRUPDWLRQ
8QDXGLWHG3UR)RUPD)LQDQFLDO,QIRUPDWLRQ
8QDXGLWHG3UR)RUPD)LQDQFLDO,QIRUPDWLRQ
1RQ,)56ILQDQFLDOLQIRUPDWLRQ
2SHUDWLQJFDVKIORZ
2SHUDWLQJFDVKIORZFRQYHUVLRQXQDXGLWHG
/LNHIRUOLNHJURZWKquotesdbs_dbs22.pdfusesText_28[PDF] activité brise glace réunion déquipe
[PDF] jeu pour faire connaissance groupe adulte
[PDF] expérience énergie cycle 3
[PDF] activité petite enfance crèche
[PDF] activité manuelle petite enfance
[PDF] activité pour tout petit 0 3 ans
[PDF] idees activites en creche
[PDF] activité d'éveil en crèche
[PDF] les activités déveil des tout petit fleurus
[PDF] jeux mathématiques nombres relatifs
[PDF] addition de relatifs exercices
[PDF] activité addition nombres relatifs 5ème
[PDF] exercices somme de relatifs
[PDF] soustraction relatifs 5ème